Swiss implant lowers blood sugar in diabetic mice without insulin

Swiss researchers have developed a wireless electronic implant that lowers blood sugar in diabetic mice without insulin or medication, normalizing glucose levels within one hour during successful animal trials. The device electrochemically converts excess glucose into gluconate, which the body excretes naturally. It uses platinum-coated gold nanoclusters on graphite felt as a catalyst, activated wirelessly via smartphone, with sensors automatically shutting it off once normal levels are reached. Published in Science, the six-week study on obese diabetic mice also showed significant weight loss with no tissue damage. Lead researcher Martin Fussenegger of ETH Zurich noted human clinical trials are still pending, though the team aims to develop it into a clinical medical product.